![Jeffrey N. Meshulam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey N. Meshulam
Plus aucun poste en cours
Profil
Jeffrey N.
Meshulam was the founder of Cellular Products, Inc. (founded in 1983) and served as Chairman, President & Chief Executive Officer in 1996.
Former positions include Director at the American Diabetes Association, Director-Corporate Development at the Institute of Human Virology (1996-2004), President, Chief Operating Officer & Director at Profectus BioSciences, Inc. (2014), President at Northern Scientific, Inc., and Vice President at the International Retrovirology Association.
Education includes an undergraduate degree from the State University of New York at Buffalo, conferred in 1979.
Anciens postes connus de Jeffrey N. Meshulam
| Sociétés | Poste | Fin |
|---|---|---|
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops preventive and therapeutic vaccines | President | 01/01/2023 |
Institute of Human Virology
 Institute of Human Virology Other Consumer ServicesConsumer Services College/University | Corporate Officer/Principal | 01/01/2004 |
Cellular Products, Inc.
 Cellular Products, Inc. Medical SpecialtiesHealth Technology Manufactures biotechnology materials for diagnostic test kits | Directeur Général | 01/01/1996 |
International Retrovirology Association
 International Retrovirology Association Medical/Nursing ServicesHealth Services The International Retrovirology Association (IRVA) is dedicated to advancing research on human T-lymphotropic virus (HTLV) infections and related diseases. The private company is located in the US. It fosters collaboration among researchers, provides a platform for critical analysis of new data, and disseminates knowledge through guidelines, clinical trials, publications, and scientific meetings. IRVA also supports awareness initiatives like World HTLV Day and promotes calls to action to enhance the response to HTLV-1. Its resources include multilingual patient advocacy and informational materials, recent research updates, and news to support both the scientific community and public awareness. | Corporate Officer/Principal | - |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Directeur/Membre du Conseil | - |
Formation de Jeffrey N. Meshulam
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Cellular Products, Inc.
Cellular Products, Inc. Medical SpecialtiesHealth Technology Manufactures biotechnology materials for diagnostic test kits | Health Technology |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops preventive and therapeutic vaccines | Health Technology |
Institute of Human Virology
Institute of Human Virology Other Consumer ServicesConsumer Services College/University | Consumer Services |
Northern Scientific, Inc. | |
International Retrovirology Association
International Retrovirology Association Medical/Nursing ServicesHealth Services The International Retrovirology Association (IRVA) is dedicated to advancing research on human T-lymphotropic virus (HTLV) infections and related diseases. The private company is located in the US. It fosters collaboration among researchers, provides a platform for critical analysis of new data, and disseminates knowledge through guidelines, clinical trials, publications, and scientific meetings. IRVA also supports awareness initiatives like World HTLV Day and promotes calls to action to enhance the response to HTLV-1. Its resources include multilingual patient advocacy and informational materials, recent research updates, and news to support both the scientific community and public awareness. | Health Services |
Choisissez Zonebourse 
